Purdue Pharma Ordered to Pay $5.5 Billion for Its Role in the Opioid Crisis

Yesterday — April 29, 2026 — a federal judge in New Jersey ordered Purdue Pharma to pay $5.5 billion in criminal fines and penalties for its role in fueling America’s opioid epidemic.

Purdue Pharma made OxyContin, a powerful prescription painkiller the company aggressively marketed to doctors throughout the 1990s and 2000s. Internal records and court filings show the company downplayed how addictive the drug was and pushed for higher doses and longer prescriptions than were medically necessary.

The consequences were catastrophic. Millions of Americans became dependent on prescription opioids, and many turned to heroin or fentanyl when prescriptions became harder to get. The opioid epidemic has killed more than 500,000 Americans since 1999, according to the Centers for Disease Control and Prevention.

What the $5.5 Billion Sentence Means

The sentence was imposed in Newark federal court and is part of a criminal plea deal Purdue Pharma agreed to. Under the agreement, most of the $5.5 billion will not be paid directly to the government in cash. Instead, the Justice Department will collect $225 million directly, while Purdue’s remaining assets will be directed into a larger $7.4 billion settlement fund.

That fund is intended to:

• Repay state and local governments that spent years dealing with the costs of the opioid crisis — treatment programs, emergency services, and more
• Put money toward direct payments for people who were harmed by opioid addiction

Purdue Pharma plans to dissolve its existing operations and emerge from bankruptcy as a new nonprofit company focused on making opioid addiction treatment and overdose-reversal medicines.

Who May Be Affected

People who were seriously harmed by prescription opioid addiction — including OxyContin — may have options worth exploring. That can include people who:

• Were prescribed OxyContin or other opioids and became dependent on them
• Suffered serious health consequences from opioid addiction
• Lost a family member to an opioid overdose linked to prescription drugs

These cases are complex and depend on specific facts. But if you or a family member were seriously harmed and believe a drug company or prescriber played a role, it may be worth finding out whether you qualify for help.

Common Questions

What did Purdue Pharma do wrong?

Purdue Pharma made OxyContin and marketed it to doctors as safe and effective even when internal evidence showed the drug was highly addictive. The company pushed for prescriptions to be written at higher doses and for longer periods than patients needed, fueling widespread addiction.

What is the $7.4 billion settlement for?

The larger $7.4 billion fund is intended to help state and local governments recover costs tied to the opioid epidemic, and to provide direct payments to individuals who were seriously harmed by opioid addiction.

Does the sentence help individual victims?

The sentence clears the way for Purdue to dissolve and direct its assets into a settlement fund. A portion of that fund is specifically set aside for people who were directly harmed by opioid addiction.

Who is the Sackler family?

The Sackler family owned Purdue Pharma and withdrew billions of dollars from the company before it declared bankruptcy. Federal investigators argued that money was moved to shield it from being paid to opioid victims.

How do I know if I may qualify for help?

If you or a family member were seriously harmed by OxyContin or other prescription opioids — including becoming dependent or dying from an overdose — fill out the form on this page. There is no cost to check and no obligation.